Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. 1994

R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
Chiron Corporation, Emeryville, California 94608.

Screening a diverse, combinatorial library of ca. 5000 synthetic dimer and trimer N-(substituted)glycine "peptides" yielded novel, high-affinity ligands for 7-transmembrane G-protein-coupled receptors. The peptoid library was efficiently assembled using readily available chemical building blocks. The choice of side chains was biased to resemble known ligands to 7-transmembrane G-protein-coupled receptors. All peptides were screened in solution-phase, competitive radioligand-binding assays. Peptoid trimer CHIR 2279 binds to the alpha 1-adrenergic receptor with a Ki of 5 nM, and trimer CHIR 4531 binds to the mu-opiate receptor with a Ki of 6 nM. This represents the first example of the discovery of high-affinity receptor ligands from a combinatorial library of non-natural chemical entities.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D005998 Glycine A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. Aminoacetic Acid,Glycine, Monopotassium Salt,Glycine Carbonate (1:1), Monosodium Salt,Glycine Carbonate (2:1), Monolithium Salt,Glycine Carbonate (2:1), Monopotassium Salt,Glycine Carbonate (2:1), Monosodium Salt,Glycine Hydrochloride,Glycine Hydrochloride (2:1),Glycine Phosphate,Glycine Phosphate (1:1),Glycine Sulfate (3:1),Glycine, Calcium Salt,Glycine, Calcium Salt (2:1),Glycine, Cobalt Salt,Glycine, Copper Salt,Glycine, Monoammonium Salt,Glycine, Monosodium Salt,Glycine, Sodium Hydrogen Carbonate,Acid, Aminoacetic,Calcium Salt Glycine,Cobalt Salt Glycine,Copper Salt Glycine,Hydrochloride, Glycine,Monoammonium Salt Glycine,Monopotassium Salt Glycine,Monosodium Salt Glycine,Phosphate, Glycine,Salt Glycine, Monoammonium,Salt Glycine, Monopotassium,Salt Glycine, Monosodium

Related Publications

R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
December 2003, Life sciences,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
November 2005, The Journal of clinical investigation,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
April 2008, Journal of the American Chemical Society,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
January 1996, Methods in enzymology,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
January 2004, Current pharmaceutical design,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
March 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
July 2006, Expert opinion on drug discovery,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
October 2010, Pharmaceuticals (Basel, Switzerland),
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
August 2013, Future medicinal chemistry,
R N Zuckermann, and E J Martin, and D C Spellmeyer, and G B Stauber, and K R Shoemaker, and J M Kerr, and G M Figliozzi, and D A Goff, and M A Siani, and R J Simon
January 2006, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!